MedTrace Logo

Synergic Effects of Ultrasound and Laser on the Pain Relief and Functionality

NCT02154893 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2015-12-04

No results posted yet for this study

Summary

There are several therapeutic effects of the ultrasound (US) or low level laser therapy (LLLT), including pain relief, increase of microcirculation, modulation of inflammatory response and accelerated tissue repair. The investigators hypothesis was that a combination of US, LLLT and therapeutic exercise may maximize clinical outcome.

Conditions

Interventions

DEVICE

Ultrasound plus Laser and therapeutic exercise

Ultrasound with frequency 1 Mhz and infrared laser with output power at 100 mW. The resistance training was performed.The treatments are done once a week, for 3 months.

DEVICE

Ultrasound plus Laser

Ultrasound with frequency 1 Mhz and infrared laser with output power at 100 mW. The treatments are done once a week, for 3 months.

DEVICE

Utrasound plus Laser Placebo

The device with Ultrasound and infrared laser without emitting electromagnetic or mechanical waves was applied (null dose).

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

    collaborator OTHER_GOV

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

    collaborator OTHER_GOV

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Vanderlei S Bagnato, Ph.D · Physics Institute of São Carlos (IFSC), University of São Paulo (USP)

  • Alessandra R Paolillo, Ph.D · Physics Institute of São Carlos (IFSC), University of São Paulo (USP)

  • Fernanda R Paolillo, Ph.D · Physics Institute of São Carlos (IFSC), University of São Paulo (USP)

  • Jéssica João, PT · Physics Institute of São Carlos (IFSC), University of São Paulo (USP)

  • Herbert João, Msc · Physics Institute of São Carlos (IFSC), University of São Paulo (USP)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02154893 on ClinicalTrials.gov